<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zdor</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы здоровья и экологии</journal-title><trans-title-group xml:lang="en"><trans-title>Health and Ecology Issues</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2220-0967</issn><issn pub-type="epub">2708-6011</issn><publisher><publisher-name>Gomel State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.51523/2708-6011.2024-21-2-11</article-id><article-id custom-type="elpub" pub-id-type="custom">zdor-2717</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНАЯ МЕДИЦИНА И БИОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EXPERIMENTAL MEDICINE AND BIOLOGY</subject></subj-group></article-categories><title-group><article-title>Корреляционные взаимосвязи между уровнем микроРНК и мРНК вовлекаемых в патологический ангиогенез в условиях экспериментального цирроза печени</article-title><trans-title-group xml:lang="en"><trans-title>Correlation relationships between the levels of microRNA and mRNA involved in pathological angiogenesis in experimental liver cirrhosis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1309-4248</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лебедева</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Lebedeva</surname><given-names>E. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лебедева Елена Ивановна, к.б.н., доцент, доцент кафедры гистологии, цитологии и эмбриологии,</p><p>г. Витебск</p></bio><bio xml:lang="en"><p>Elena I. Lebedeva, Candidate of Biological Sciences, Associate Professor at the Department of Histology, Cytology and Embryology</p><p>Vitebsk</p></bio><email xlink:type="simple">lebedeva.ya-elenale2013@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2796-4240</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Щастный</surname><given-names>А. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Shchastniy</surname><given-names>A. T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Щастный Анатолий Тадеушевич, д.м.н., профессор, заведующий кафедрой госпитальной хирургии с курсомФПКиПК</p><p>г. Витебск</p></bio><bio xml:lang="en"><p>Anatoliy T. Shchastniy, Doctor of Medical Sciences, Professor, Head of the Department of Hospital Surgery with the course of Advanced Training and Retraining</p><p>Vitebsk </p></bio><email xlink:type="simple">rectorvsmu@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5513-970X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бабенко</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Babenka</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бабенко Андрей Сергеевич, к.х.н., доцент, доцент кафедры общей химии</p><p>г. Минск</p></bio><bio xml:lang="en"><p>Andrei S. Babenka, Candidate of Chemical Sciences, Associate Professor at the Department of General Chemistry</p><p>Мinsk</p></bio><email xlink:type="simple">labmdbt@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3808-8832</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зиновкин</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zinovkin</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зиновкин Дмитрий Александрович, к.б.н., доцент, доцент кафедры патологической анатомии</p><p>г. Гомель</p></bio><bio xml:lang="en"><p>Dmitry A. Zinovkin, Candidate of Biological Sciences, Associate Professor, Associate Professor at the Department of Pathology</p><p>Gomel</p></bio><email xlink:type="simple">zinovkin_da@gsmu.by</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0896-5611</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Надыров</surname><given-names>Э. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nadyrov</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Надыров Эльдар Аркадьевич, к.м.н., доцент, доцент кафедры патологической анатомии</p><p>г. Гомель</p></bio><bio xml:lang="en"><p>Eldar A. Nadyrov, Candidate of Medical Sciences, Associate Professor, Associate Professor at the Departments of Pathological Anatomy and Histology, Cytology and Embryology</p><p> Gomel</p></bio><email xlink:type="simple">nadyrov2006@rambler.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Витебский государственный ордена Дружбы народов медицинский университет</institution></aff><aff xml:lang="en"><institution>Vitebsk State Order of Peoples’ Friendship Medical University</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Белорусский государственный медицинский университет.</institution></aff><aff xml:lang="en"><institution>Belarusian State Medical University</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Гомельский государственный медицинский университет</institution></aff><aff xml:lang="en"><institution>Gomel State Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>05</month><year>2024</year></pub-date><volume>21</volume><issue>2</issue><fpage>87</fpage><lpage>96</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Лебедева Е.И., Щастный А.Т., Бабенко А.С., Зиновкин Д.А., Надыров Э.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Лебедева Е.И., Щастный А.Т., Бабенко А.С., Зиновкин Д.А., Надыров Э.А.</copyright-holder><copyright-holder xml:lang="en">Lebedeva E.I., Shchastniy A.T., Babenka A.S., Zinovkin D.A., Nadyrov E.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.gsmu.by/jour/article/view/2717">https://journal.gsmu.by/jour/article/view/2717</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования. Выявить взаимосвязи между уровнем микроРНК и мРНК при патологическом ангиогенезе в условиях экспериментального токсического цирроза печени.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Фиброз и цирроз печени у крыс-самцов линии Wistar индуцировали свежеприготовленным раствором тиоацетамида в течение 17 недель. Динамику процесса изучали в девяти временных точках. Измеряли площадь междольковых вен и междольковых артерий в микрометрах. Подсчитывали количество междольковых артерий, междольковых вен и синусоидных капилляров. Уровень экспрессии мРНК генов Ang, Vegfa, Tweak, Fn14, Notch1, Notch2 и микроРНК-195-5р, микроРНК-664-3р, микроРНК-489-3р, микроРНК-3085, микроРНК-3558-3р в печени определяли методом полимеразной цепной реакции в режиме реального времени.</p></sec><sec><title>Результаты</title><p>Результаты. Установлено, что при прогрессирующем венозном ангиогенезе, а также на фоне изменения количества междольковых вен, синусоидных капилляров, площади междольковых вен характер и сила корреляционных взаимодействий между генами Ang, Vegfa, Tweak, Fn14, Notch1, Notch2 и микроРНК-195-5р, микроРНК-664-3р, микроРНК-489-3р, микроРНК-3085, микроРНК-3558-3р связаны со стадией фиброза и цирроза печени. Выявлены прямые сильные, средние и умеренные корреляционные связи (p &lt; 0,01) между генами Ang, Vegfa, Tweak, Fn14, Notch1, Notch2 на протяжении всего эксперимента.</p></sec><sec><title>Заключение</title><p>Заключение. Полученные результаты свидетельствуют о том, что исследуемые нами микроРНК-195-5р, микроРНК-664-3р, микроРНК-489-3р, микроРНК-3085, микроРНК-3558-3р вовлекаются в процессы перестройки внутрипеченочного сосудистого русла на разных стадиях экспериментального токсического фиброза и цирроза печени. Результаты исследования позволяют не только раскрыть дополнительные механизмы формирования указанных состояний, но и выявить биологическую роль изученных микроРНК в прогрессировании фиброза и цирроза печени в качестве потенциальных мишеней для изучения патогенеза и разработки методов лечения.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective. To identify the relationships between the levels of microRNA and mRNA during pathological angiogenesis under the conditions of experimental toxic liver cirrhosis.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Fibrosis and liver cirrhosis were induced in male Wistar rats using a freshly prepared solution of thioacetamide over 17 weeks. The dynamics of the process were studied at 9 time points. The areas of interlobular veins and interlobular arteries were measured in micrometers. The numbers of interlobular arteries, interlobular veins, and sinusoidal capillaries were counted. The expression levels of mRNA genes Ang, Vegfa, Tweak, Fn14, Notch1, Notch2, and microRNAs-195-5p, microRNAs-664-3p, microRNAs-489-3p, microRNAs-3085, microRNAs-3558-3p in the liver were determined by real-time polymerase chain reaction.</p></sec><sec><title>Results</title><p>Results. It was found that during progressive venous angiogenesis, as well as against the background of changes in the number of interlobular veins, sinusoidal capillaries, and the area of interlobular veins, the nature and strength of correlational interactions between the genes Ang, Vegfa, Tweak, Fn14, Notch1, Notch2, and microRNAs-195-5p, microRNAs-664-3p, microRNAs-489-3p, microRNAs-3085, microRNAs-3558-3p are associated with the stage of fibrosis and liver cirrhosis. Strong, moderate, and mild correlational links (p&lt;0.01) were identified between the genes Ang, Vegfa, Tweak, Fn14, Notch1, Notch2 throughout the experiment.</p></sec><sec><title>Conclusion</title><p>Conclusion. The obtained results indicate that the studied microRNAs - microRNAs-195-5p, microRNAs-664-3p, microRNAs-489-3p, microRNAs-3085, microRNAs-3558-3p - are involved in the processes of restructuring the intrahepatic vascular bed at different stages of experimental toxic fibrosis and liver cirrhosis. The results of the study not only reveal additional mechanisms of formation of the indicated conditions but also identify the biological role of the studied microRNAs in the progression of fibrosis and liver cirrhosis as potential targets for studying pathogenesis and developing treatment methods.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>эксперимент</kwd><kwd>фиброз и цирроз печени</kwd><kwd>экспрессия мРНК и микроРНК</kwd><kwd>корреляционный анализ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>experiment</kwd><kwd>liver fibrosis and cirrhosis</kwd><kwd>mRNA and microRNA expression</kwd><kwd>correlational analysis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Iwakiri Y, Trebicka J. Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy. JHEP Rep. 2021;3(4):100316. DOI: https://doi.org/10.1016/j.jhepr.2021.100316</mixed-citation><mixed-citation xml:lang="en">Iwakiri Y, Trebicka J. Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy. JHEP Rep. 2021;3(4):100316. DOI: https://doi.org/10.1016/j.jhepr.2021.100316</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Lin Y, Dong MQ, Liu ZM, Xu M, Huang ZH, Liu HJ, et al. A strategy of vascular-targeted therapy for liver fibrosis. J Hepatology. 2022;76(3):660-675. DOI: https://doi.org/10.1002/hep.32299</mixed-citation><mixed-citation xml:lang="en">Lin Y, Dong MQ, Liu ZM, Xu M, Huang ZH, Liu HJ, et al. A strategy of vascular-targeted therapy for liver fibrosis. J Hepatology. 2022;76(3):660-675. DOI: https://doi.org/10.1002/hep.32299</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmad A, Nawaz MI. Molecular mechanism of VEGF and its role in pathological angiogenesis. J Cell Biochem. 2022;123(12):1938-1965. DOI: https://doi.org/10.1002/jcb.30344</mixed-citation><mixed-citation xml:lang="en">Ahmad A, Nawaz MI. Molecular mechanism of VEGF and its role in pathological angiogenesis. J Cell Biochem. 2022;123(12):1938-1965. DOI: https://doi.org/10.1002/jcb.30344</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ghalehbandi S, Yuzugulen J, Pranjol MdZI, Pourgholam MH. The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF. Eur J Pharmacol. 2023;949:175586. DOI: https://doi.org/10.1016/j.ejphar.2023.175586</mixed-citation><mixed-citation xml:lang="en">Ghalehbandi S, Yuzugulen J, Pranjol MdZI, Pourgholam MH. The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF. Eur J Pharmacol. 2023;949:175586. DOI: https://doi.org/10.1016/j.ejphar.2023.175586</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bauer D, Kozbial K, Schwabl P, Chromy D, Simbrunner B, Stättermayer AF, et al. Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertension. Dig Liver Dis. 2022;54(9):1222-1229. DOI: https://doi.org/10.1016/j.dld.2022.02.013</mixed-citation><mixed-citation xml:lang="en">Bauer D, Kozbial K, Schwabl P, Chromy D, Simbrunner B, Stättermayer AF, et al. Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertension. Dig Liver Dis. 2022;54(9):1222-1229. DOI: https://doi.org/10.1016/j.dld.2022.02.013</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lefere S, Van de Velde F, Hoorens A, Raevens S, Van Campenhout S, Vandierendonck A, et al. Angiopoietin-2 Promotes Pathological Angiogenesis and Is a Therapeutic Target in Murine Nonalcoholic Fatty Liver Disease. Hepatology. 2019;69(3):1087-1104. DOI: https://doi.org/10.1002/hep.30294</mixed-citation><mixed-citation xml:lang="en">Lefere S, Van de Velde F, Hoorens A, Raevens S, Van Campenhout S, Vandierendonck A, et al. Angiopoietin-2 Promotes Pathological Angiogenesis and Is a Therapeutic Target in Murine Nonalcoholic Fatty Liver Disease. Hepatology. 2019;69(3):1087-1104. DOI: https://doi.org/10.1002/hep.30294</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mack JJ, Iruela-Arispe ML. NOTCH regulation of the endothelial cell phenotype. Curr Opin Hematol. 2018;25(3):212-218. DOI: https://doi.org/10.1097/MOH.0000000000000425</mixed-citation><mixed-citation xml:lang="en">Mack JJ, Iruela-Arispe ML. NOTCH regulation of the endothelial cell phenotype. Curr Opin Hematol. 2018;25(3):212-218. DOI: https://doi.org/10.1097/MOH.0000000000000425</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng Y, Wang J, Zhao T, Wang L, Wang J. Modulation of the VEGF/AKT/eNOS signaling pathway to regulate liver angiogenesis to explore the anti-hepatic fibrosis mechanism of curcumol. J Ethnopharmacol. 2021;280:114480. DOI: https://doi.org/10.1016/j.jep.2021.114480</mixed-citation><mixed-citation xml:lang="en">Zheng Y, Wang J, Zhao T, Wang L, Wang J. Modulation of the VEGF/AKT/eNOS signaling pathway to regulate liver angiogenesis to explore the anti-hepatic fibrosis mechanism of curcumol. J Ethnopharmacol. 2021;280:114480. DOI: https://doi.org/10.1016/j.jep.2021.114480</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang W, Han L, Wen Y, Su L, Li Y, Luo X. Electroacupuncture reverses endothelial cell death and promotes angiogenesis through the VEGF/Notch signaling pathway after focal cerebral ischemia-reperfusion injury. Brain Behav. 2023;13(3):e2912. DOI: https://doi.org/10.1002/brb3.2912</mixed-citation><mixed-citation xml:lang="en">Zhang W, Han L, Wen Y, Su L, Li Y, Luo X. Electroacupuncture reverses endothelial cell death and promotes angiogenesis through the VEGF/Notch signaling pathway after focal cerebral ischemia-reperfusion injury. Brain Behav. 2023;13(3):e2912. DOI: https://doi.org/10.1002/brb3.2912</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J, Yang L, Mei J, Li Z, Huang Y, Sun H, et al. Knockdown of Notch Suppresses Epithelial-mesenchymal Transition and Induces Angiogenesis in Oral Submucous Fibrosis by Regulating TGF-β1. Biochem Genet. 2023;62:1055-1069. DOI: https://doi.org/10.1007/s10528-023-10452-3</mixed-citation><mixed-citation xml:lang="en">Wang J, Yang L, Mei J, Li Z, Huang Y, Sun H, et al. Knockdown of Notch Suppresses Epithelial-mesenchymal Transition and Induces Angiogenesis in Oral Submucous Fibrosis by Regulating TGF-β1. Biochem Genet. 2023;62:1055-1069. DOI: https://doi.org/10.1007/s10528-023-10452-3</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y, Zeng W, Xia Y. TWEAK/Fn14 axis is an important player in fibrosis. J Cell Physiol. 2021;236(5):3304-3316. DOI: https://doi.org/10.1002/jcp.30089</mixed-citation><mixed-citation xml:lang="en">Zhang Y, Zeng W, Xia Y. TWEAK/Fn14 axis is an important player in fibrosis. J Cell Physiol. 2021;236(5):3304-3316. DOI: https://doi.org/10.1002/jcp.30089</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Dwyer BJ, Jarman EJ, Gogoi-Tiwari J, Ferreira-Gonzalez S, Boulter L, Guest RV, et al. TWEAK/Fn14 signalling promotes cholangiocarcinoma niche formation and progression. J. Hepatol. 2021;74(4):860-872. DOI: https://doi.org/10.1016/j.jhep.2020.11.018</mixed-citation><mixed-citation xml:lang="en">Dwyer BJ, Jarman EJ, Gogoi-Tiwari J, Ferreira-Gonzalez S, Boulter L, Guest RV, et al. TWEAK/Fn14 signalling promotes cholangiocarcinoma niche formation and progression. J. Hepatol. 2021;74(4):860-872. DOI: https://doi.org/10.1016/j.jhep.2020.11.018</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Short C, Zhong A, Xu J, Mahdi E, Glazier A, Malkoff N, et al. TWEAK/FN14 promotes profibrogenic pathway activation in Prominin-1-expressing hepatic progenitor cells in biliary atresia. Hepatology. 2023;77(5):1639-1653. DOI: https://doi.org/10.1097/HEP.0000000000000026</mixed-citation><mixed-citation xml:lang="en">Short C, Zhong A, Xu J, Mahdi E, Glazier A, Malkoff N, et al. TWEAK/FN14 promotes profibrogenic pathway activation in Prominin-1-expressing hepatic progenitor cells in biliary atresia. Hepatology. 2023;77(5):1639-1653. DOI: https://doi.org/10.1097/HEP.0000000000000026</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Li J, Gong J, Li X, Shen L, Xie Y, Zhang R. MicroRNA-34a promotes CMECs apoptosis and upregulate inflammatory cytokines, thus worsening CMECs damage and inhibiting angiogenesis by negatively targeting the Notch signaling pathway. J Cell Biochem. 2019;120(2):1598-1609. DOI: https://doi.org/10.1002/jcb.27433</mixed-citation><mixed-citation xml:lang="en">Li J, Gong J, Li X, Shen L, Xie Y, Zhang R. MicroRNA-34a promotes CMECs apoptosis and upregulate inflammatory cytokines, thus worsening CMECs damage and inhibiting angiogenesis by negatively targeting the Notch signaling pathway. J Cell Biochem. 2019;120(2):1598-1609. DOI: https://doi.org/10.1002/jcb.27433</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Fan J, Xu W, Nan S, Chang M, Zhang Y. MicroRNA-384-5p Promotes Endothelial Progenitor Cell Proliferation and Angiogenesis in Cerebral Ischemic Stroke through the Delta-Likeligand 4-Mediated Notch Signaling Pathway. Cerebrovasc Dis. 2020;49(1):39-54. DOI: https://doi.org/10.1159/000503950</mixed-citation><mixed-citation xml:lang="en">Fan J, Xu W, Nan S, Chang M, Zhang Y. MicroRNA-384-5p Promotes Endothelial Progenitor Cell Proliferation and Angiogenesis in Cerebral Ischemic Stroke through the Delta-Likeligand 4-Mediated Notch Signaling Pathway. Cerebrovasc Dis. 2020;49(1):39-54.. DOI: https://doi.org/10.1159/000503950</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">de Oliveira ARCP, Castanhole-Nunes MMU, Biselli-Chicote PM, Pavarino ÉC, da Silva RCMA, da Silva RF, et al. Differential expression of angiogenesis-related miRNAs and VEGFA in cirrhosis and hepatocellular carcinoma. Arch Med Sci. 2020;16(5):1150-1157. DOI: https://doi.org/10.5114/aoms.2020.97967</mixed-citation><mixed-citation xml:lang="en">de Oliveira ARCP, Castanhole-Nunes MMU, Biselli-Chicote PM, Pavarino ÉC, da Silva RCMA, da Silva RF, et al. Differential expression of angiogenesis-related miRNAs and VEGFA in cirrhosis and hepatocellular carcinoma. Arch Med Sci. 2020;16(5):1150-1157. DOI: https://doi.org/10.5114/aoms.2020.97967</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang T, Yang Y, Wang B, Wang L, Wang D, Cao N, et al. XSSJS inhibits hepatic fibrosis by promoting the miR-29b-3p/VEGFA axis in vitro and in vivo. Biosci Rep. 2022;42(2):BSR20212241. DOI: https://doi.org/10.1042/BSR20212241</mixed-citation><mixed-citation xml:lang="en">Zhang T, Yang Y, Wang B, Wang L, Wang D, Cao N, et al. XSSJS inhibits hepatic fibrosis by promoting the miR-29b-3p/VEGFA axis in vitro and in vivo. Biosci Rep. 2022;42(2):BSR20212241. DOI: https://doi.org/10.1042/BSR20212241</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Lebedeva EI, Shchastniy AT, Babenka AS, Zinovkin DA. Relationships between Cxcl12, Tweak, Notch1, and Yap mRNA Expression Levels in Molecular Mechanisms of Liver Fibrogenesis. Molecular Biology. 2024;58(1):102-111. DOI: https://doi.org/10.1134/S0026893324010060</mixed-citation><mixed-citation xml:lang="en">Lebedeva EI, Shchastniy AT, Babenka AS, Zinovkin DA. Relationships between Cxcl12, Tweak, Notch1, and Yap mRNA Expression Levels in Molecular Mechanisms of Liver Fibrogenesis. Molecular Biology. 2024;58(1):102-111. DOI: https://doi.org/10.1134/S0026893324010060</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Y, Wang X. Chen, Y. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127-D131. DOI: https://doi.org/10.1093/nar/gkz757</mixed-citation><mixed-citation xml:lang="en">Chen Y, Wang X. Chen, Y. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127-D131. DOI: https://doi.org/10.1093/nar/gkz757</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lebedeva EI, Babenka AS, Shchastniy AT. The dynamics of microRNAs level associated with pathological venous angiogenesis in experimental toxic liver fibrosis in rats. Genes &amp; Cells. 2024;19(1):181-199. DOI: https://doi.org/10.17816/gc622891</mixed-citation><mixed-citation xml:lang="en">Lebedeva EI, Babenka AS, Shchastniy AT. The dynamics of microRNAs level associated with pathological venous angiogenesis in experimental toxic liver fibrosis in rats. Genes &amp; Cells. 2024;19(1):181-199. DOI: https://doi.org/10.17816/gc622891</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Лебедева ЕИ, Красочко ПА, Щастный АТ. Бабенко АС, Ковалев НА. Борисовец ДС. Рекомендации по оценке прогрессирования и регресса токсического фиброза печени в доклинических исследованиях. Минск: РУП «Институт экспериментальной ветеринарии им. С.Н. Вышелесского», 2023. 8 с.</mixed-citation><mixed-citation xml:lang="en">Lebedeva EI, Krasochko PA, Shchastniy AT. Babenkа AS, Kovalev NA. Borisovets DS. Recommendations for assessing the progression and regression of toxic liver fibrosis in preclinical studies. Minsk: “Institute of Experimental Veterinary Medicine named after. S.N. Vyshelesskogo”, 2023. 8 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Wilhelm A, Shepherd EL, Amatucci A, Munir M, Reynolds G, Humphreys E, et al. Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation. J Pathol. 2016;239(1):109-121. DOI: https://doi.org/10.1002/path.4707</mixed-citation><mixed-citation xml:lang="en">Wilhelm A, Shepherd EL, Amatucci A, Munir M, Reynolds G, Humphreys E, et al. Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation. J Pathol. 2016;239(1):109-121. DOI: https://doi.org/10.1002/path.4707</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Androvic P, Valihrach L, Elling J, Sjoback R, Kubista M. Two-tailed RT-qPCR: a novel method for highly accurate miRNA quantification. Nucleic Acids Res. 2017;45(15):e144. DOI: https://doi.org/10.1093/nar/gkx588</mixed-citation><mixed-citation xml:lang="en">Androvic P, Valihrach L, Elling J, Sjoback R, Kubista M. Two-tailed RT-qPCR: a novel method for highly accurate miRNA quantification. Nucleic Acids Res. 2017;45(15):e144. DOI: https://doi.org/10.1093/nar/gkx588</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
